Search

Site Search

Search
Showing 1 - 10 of 36 results
About the CF Foundation | Drug Pipeline | Genetic Therapies
Genzyme and Cystic Fibrosis Foundation Therapeutics Announce Collaboration to Discover New CF Drugs

New Effort Will Search for Potential Therapies Targeting the Most Common Mutation of Cystic Fibrosis

Press Release |
| 4 min read
About the CF Foundation | CFTR Modulators | Genetic Therapies
The Cystic Fibrosis Foundation Applauds FDA Approval of Kalydeco™, First Drug to Address the Underlying Cause of Cystic Fibrosis

Kalydeco Marks the Latest Success of the Cystic Fibrosis Foundation’s Venture Philanthropy Model

Press Release |
| 5 min read
About the CF Foundation | CFTR Modulators | Genetic Therapies
Cystic Fibrosis Foundation Applauds Successful Phase 3 Results of Ivacaftor (Kalydeco™) and Lumacaftor (VX-809) Drug Combination for People with Two Copies of F508del Mutation of Cystic Fibrosis

CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process

Press Release |
| 5 min read
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT) | Genetic Therapies
Cystic Fibrosis Foundation Therapeutics Announces $15 Million Research Project with Shire for Development of Novel CF Treatment
Press Release |
| 3 min read
About the CF Foundation | CFTR Modulators | Genetic Therapies
Cystic Fibrosis Foundation Issues Statement on The New England Journal of Medicine Study on the Benefits of the Ivacaftor/Lumacaftor Combination Drug
Press Release |
| 3 min read
About the CF Foundation | Genetic Therapies | Research
PTC Therapeutics Announces Publication of Preclinical Data in PNAS
Press Release |
| 6 min read
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT) | Genetic Therapies
Copernicus to Receive Continued Support from Cystic Fibrosis Foundation Therapeutics to Further Develop Non-Viral Gene Therapy for Cystic Fibrosis
Press Release |
| 3 min read
Genetic Therapies
Webinar en español: Terapias genéticas para la FQ

La fibrosis quística (FQ) es una enfermedad genética. Escuche las presentaciones de los expertos, el Doctor Fadel Ruiz, director del centro de fibrosis quística de Baylor y el Doctor Carlos Milla, director del centro de fibrosis quística de Stanford y sus respuestas a las principales preguntas de la comunidad sobre terapias genéticas para la FQ. El panel fue moderado por Sylvia Mazuera, madre de dos hijos, el menor de los cuales tiene FQ.
Online only
Virtual
Genetic Therapies
mRNA Therapy for Cystic Fibrosis

mRNA therapy is one way to deliver the correct genetic instructions to cells, which would allow them to make functional CFTR protein regardless of an individual’s CF mutations.

3 min read
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT) | Genetic Therapies
EPIX Pharmaceuticals Achieves $1.25 Million Milestone From Cystic Fibrosis Foundation Therapeutics
Press Release |
| 6 min read